ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
99,163.02
1.44%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX
  6. Donaco International Ltd (DNA)

  7. Donaco International Ltd (DNA) News

DNA

Donaco (DNA)

Donaco International Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:DNA
DateTimeSourceHeadlineSymbolCompany
11/10/20156:52PMThe Motley FoolPacker backs Crown Resorts Ltd with $200 million betASX:DNADonaco International Ltd
03/27/200911:13AMDow Jones NewsUPDATE: FDA 'Unclear' If Avastin Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
03/27/200910:35AMDow Jones NewsFDA 'Unclear' If Genentech Drug Data Backs Expanded ApprovalNYSE:DNAGenentech Inc. (Delisted 3/27/09)
03/26/20095:23AMDow Jones NewsUPDATE: Roche Effectively Seals $46.8 Billion Genentech TakeoverNYSE:DNAGenentech Inc.
03/26/20093:05AMDow Jones NewsRoche Completes Genentech Takeover, Holds 93.2%NYSE:DNAGenentech Inc.
03/26/20092:37AMDow Jones NewsRoche Completes Tender Offer For Genentech, Holds 93.2%NYSE:DNAGenentech Inc.
03/25/20098:44AMDow Jones News2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay PlanNYSE:DNAGenentech Inc.
03/25/20096:43AMDow Jones NewsUPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGMNYSE:DNAGenentech Inc.
03/24/20092:08PMDow Jones NewsRoche Says RiskMetrics Backs Genentech Takeover At $95/ShareNYSE:DNAGenentech Inc.
03/19/20091:09PMDow Jones NewsEU Panel Backs Novartis' Glivec In Kit-positive GISTNYSE:DNAGenentech Inc.
03/18/20099:55AMDow Jones NewsRoche Shares Down On Actemra; Herceptin Success Of Little HelpNYSE:DNAGenentech Inc.
03/18/20093:16AMDow Jones NewsRoche's Herceptin Extends Life In Aggressive Stomach CancerNYSE:DNAGenentech Inc.
03/18/20092:33AMDow Jones NewsRoche: Herceptin Prolongs Life In Stomach CancerNYSE:DNAGenentech Inc.
03/18/200912:32AMDow Jones NewsUPDATE: Chugai,Roche Face Arthritis Drug Side Effect SetbackNYSE:DNAGenentech Inc.
03/17/20099:05PMDow Jones NewsChugai:Undeniable Actemra Side Effects Tied To Patient DeathsNYSE:DNAGenentech Inc.
03/17/20096:54PMDow Jones NewsBiotechnology Group Praises Biologic Drugs BillNYSE:DNAGenentech Inc.
03/17/20094:29PMDow Jones News5th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
03/17/20093:25PMDow Jones News4th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayNYSE:DNAGenentech Inc.
03/17/20091:53PMDow Jones News3rd UPDATE: Pfizer Launches $13.5 Billion Bond Offer; Pricing TuesdayNYSE:DNAGenentech Inc.
03/17/20091:01PMDow Jones News2ndUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
03/17/200912:13PMDow Jones NewsUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayNYSE:DNAGenentech Inc.
03/16/20094:57PMDow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
03/16/20092:49PMDow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ANYSE:DNAGenentech Inc.
03/16/20092:37AMDow Jones NewsRoche Acquires Innovatis AG For EUR15 MillionNYSE:DNAGenentech Inc.
03/13/20098:45AMDow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNYSE:DNAGenentech Inc.
03/12/20094:42PMDow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNYSE:DNAGenentech Inc.
03/12/20093:15PMDow Jones NewsUS Antitrust Review May Not Pose Threat To Drug Co MergersNYSE:DNAGenentech Inc.
03/12/200910:06AMDow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionNYSE:DNAGenentech Inc.
03/12/20097:10AMDow Jones News4th UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
03/12/20094:32AMDow Jones News3rd UPDATE: Roche Seals $46.8 Billion Genentech DealNYSE:DNAGenentech Inc.
 Showing the most relevant articles for your search:ASX:DNA

Your Recent History

USOTC
GRLT
Grillit (PK)
USOTC
RDAR
Raadr (PK)
USOTC
AFFU
Affluence (PK)
USOTC
MGON
Megola (PK)
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
NXPL
NextPlat
USOTC
CBRF
CyberFuels (PK)
USOTC
PHIL
PHI (PK)
USOTC
GTCH
GBT Technologies (PK)
NYSE
IONQ
IonQ
NASDAQ
ILLR
Triller
USOTC
SPZI
Spooz (PK)
AMEX
KULR
KULR Technology
USOTC
AXXA
Exxe (PK)
COIN
SHIBUSD
SHIBA INU
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads